This natural history study is a prospective and retrospective, observational study of WHIM patients. WHIM syndrome is a rare, genetic, primary immunodeficiency disorder (a disorder in which the body's immune system does not function properly). WHIM is an acronym for some of the symptoms of the disorder - Warts, Hypogammaglobulinemia (low levels of certain antibodies), Infections and Myelokathexis (too many white blood cells in the bone marrow).This study includes 10-year retrospective (Retrospective Phase) and up to 5-year prospective (Prospective Phase) components.
Given the rarity of patients with WHIM syndrome, this study is being conducted to better understand the clinical course of untreated patients with WHIM syndrome. The goals of this Natural History Study are to define both the frequency and diversity of WHIM syndrome by specific genetic mutation, as well as to understand the clinical course and phenotype of untreated WHIM patients.
Study Type
OBSERVATIONAL
No intervention
Incidence of infections
Infections assessed by hospitalizations (including intensive care), antibiotic use, outpatient medical appointments and missed days of school/work.
Time frame: Up to five years, from time of enrollment through study completion or early termination
Severity of infections
Time frame: Up to five years, from time of enrollment through study completion or early termination
Incidence of warts
Time frame: Up to five years, from time of enrollment through study completion or early termination
Severity of warts
Warts assessed by number and size of lesions, need for surgical, systemic or topical treatment and complications.
Time frame: Up to five years, from time of enrollment through study completion or early termination
Change in quality of life over time
Quality of life as assessed by the quality of life instrument the 36-Item Short Form Survey (SF-36)
Time frame: Up to five years, from time of enrollment through study completion or early termination
Change in quality of life over time
Quality of life as assessed by the quality of life instrument the Pediatric Quality of Life Inventory (Peds-QL)
Time frame: Up to five years, from time of enrollment through study completion or early termination
Change in quality of life over time
Quality of life as assessed by the quality of life instrument the Life Quality Index (LQI)
Time frame: Up to five years, from time of enrollment through study completion or early termination
Change in quality of life over time
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Quality of life as assessed by the quality of life instrument the HPV Impact Profile (HIP)
Time frame: Up to five years, from time of enrollment through study completion or early termination
Change in medical resource utilization
Time frame: Up to five years, from time of enrollment through study completion or early termination
Change in absolute neutrophil count (ANC) over time
Time frame: Up to five years, from time of enrollment through study completion or early termination
Change in absolute lymphocyte count (ALC) over time
Time frame: Up to five years, from time of enrollment through study completion or early termination
Change in serum immunoglobulin over time
Time frame: Up to five years, from time of enrollment through study completion or early termination
Changes in anti-vaccine antibodies over time
Time frame: Up to five years, from time of enrollment through study completion or early termination